Address
New Leaf Venture Partners
7 Times Square
Suite 3502, Times Square Tower
New York, NY 10036
United States
Phone
Website
Industry
VCID: 3055
Profile
Corporate information
Also known as
NLV
Registration country
Also known as
NLV
Registration country
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| New Leaf Ventures II LP | Venture | 2007 |
| New Leaf Ventures I LP | Venture | 2005 |
Team
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Reshape Medical Inc |
United States | 1 Oct 2012 | Series C Initial investment. Round participant. Active |
|
|
|
Principia Biopharma Discoverer and developer of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. |
United States | 1 Oct 2012 | Series A |
|
|
|
IlluminOss Medical Inc A privately held medical device company dedicated to the development of minimally invasive orthopedic systems. |
United States | 1 Sep 2012 | Series C Active |
|
|
|
Oxford Immunotec Ltd |
United Kingdom | 1 Apr 2010 18 Jun 2012 |
Venture Round participant. Active |
|
|
|
BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. |
United States | 22 Mar 2012 | N/A Follow-on investment. Active |
|
|
|
Truveris Inc Health information technology company that provides management tools to sponsors of and payers of claims under prescription benefit plans. |
United States | 23 Feb 2012 | Series B Active |
|
|
|
Neuronetics Inc |
United States | 1 May 2011 1 Oct 2009 |
Series E |
|
|
|
Synageva BioPharma Corp A biopharmaceutical company dedicated to developing and commercializing novel, next generation and follow on protein therapeutics |
United States | 1 Mar 2011 1 Oct 2009 |
Venture |
|
|
|
Chimerix Inc |
United States | 1 Feb 2011 | Series F |
|
|
|
Spine Wave Inc Medical device company focused on degenerative disc disease, vertebral compression fractures, and nucleus replacement. |
United States | 1 Feb 2011 | Series E Active |
|
|
|
Spiracur Inc A medical device company focused on the development of innovative wound healing technologies. |
United States | 1 Feb 2011 | Venture |
|
|
|
Altura Medical Inc |
United States | 2 Jun 2010 | Series A Active |
|
|
|
Tioga Pharmaceuticals Inc |
United States | 1 Feb 2010 | Series A |
|
|
|
Pearl Therapeutics Inc Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases |
United States | 1 Feb 2010 | N/A |
|
|
|
XDx Inc |
United States | 7 Oct 2009 | N/A Active |
|
|
|
Direct Flow Medical Inc Medical device developer |
United States | 1 Oct 2009 | Series C Follow-on investment. Round participant. Active |
|
|
|
Presidio Pharmaceuticals Inc Drug discovery and development, focused on anti-viral indications |
United States | 1 Jul 2009 | N/A |